News About: Pharm. Industry
Pharmaceutical firms suffer dismal performance in first half
Yakup.com. said that 33 drugs makers listed on the main bourse reported poor first-half performances on tough regulations and intense competition.
In the first six months of this year, these company recorded all mi...
Restructuring to sweep pharmaceutical industry
The government’s plan to cut retail drug prices will make it harder for pharmaceutical companies to do business.
Retail drug prices are expected to fall about 17 percent on average beginning next year following a s...
Government urged to nurture domestic pharmaceutical industry
The government should work out measures to encourage pharmaceutical firms to develop more effective and cheaper drugs, strengthening the competitiveness of the country’s pharmaceutical industry, the Korea Pharmaceutic...
Pharmaceutical firms’ revenues up, profitability down
Pharmaceutical companies saw their revenues edge up in the second quarter of the year. But their ability to generate cash from a variety of operating activities fell on worsening profitability as a result of dramatic ...
KFDA approves two homegrown drugs
Demonstrating the strength of the country's R&D capabilities, the Korea Food and Drug Administration Wednesday approved two Korean drugs – Shinpoong Pharmaceutical’s anti-malarial drug ‘Pyramax’ and JW Pharmaceutical’...
Controversy brewing over KPMA president’s remarks
A controversy surrounding the recent remarks made by Korea Pharmaceutical Manufacturers Association (KPMA) president Lee Kyung-ho in a MBC radio program, Thursday, is growing.
Lee said in the program that the local...
Anti-ulcerant market edges up 3.7% in July
The domestic anti-ulcerant market increased by 3.7 percent to 70.1 billion won in July, compared with the same month last year due to the government’s merciless price cuts.
The government lowered the prices of 2,39...
Korea’s medicine business at a crossroads
With retail prices of 8,776 drugs out of the total 14,410 listed on the national health insurance that are expected to fall about 17 percent on average beginning next year following a set of government-led reforms, ma...
Bacchus-F to please Dong-A
With the possible reclassification of 48 over-the-counter (OTC) drugs as “quasi-drugs,” pharmaceutical companies, many of which saw their sales fall following a government crackdown on kickbacks given to doctors or ph...
Drug firms want equitable support from government
In order to soften the blow of massive drug price cuts on drug makers, the Ministry of Health and Welfare unveiled plans Friday to support innovative pharmaceutical companies to be selected based on their research and...
